Jury Orders Mary Kay To Pay TriStrata $26.4M In Patent Dispute Over Wrinkle Treatment
A Delaware jury has found that direct-sales cosmetics company Mary Kay infringed patents held by TriStrata Technology, Inc. for a wrinkle treatment and ordered it to pay $26.4 million plus interest...To view the full article, register now.
Already a subscriber? Click here to view full article